Abstract: The invention relates to agents and to pharmaceutical compositions for reducing the formation of amyloid and/or for promoting the disaggregation of amyloid proteins. The compositions may also be used to detect amyloid.
Abstract: The invention relates to compositions of purified filamentous bacteriophage, as well as methods that allow reproducible purification of high concentrations of filamentous bacteriophage.
Type:
Application
Filed:
August 3, 2012
Publication date:
April 4, 2013
Applicant:
NeuroPhage Pharmaceuticals, Inc.
Inventors:
Jason Wright, Antony Hitchcock, Frank Sugar, Tim Davies, Shreekant Adhikari, Nanda Menon, Quentin Florence